SURESNES, ILE-DE-FRANCE, FR
Algotherapeutix
From the company
AlgoTherapeutix (AlgoTx) is a clinical stage biotechnology company developing targeted, first in class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is a non-opioid, locally acting agent that inhibits specific nociceptive sodium channels. ATX01's lead indication is Chemotherapy-Induced Peripheral Neuropathy (CIPN), and it is in Phase 2 clinical development.
Capabilities
Products & services
Capabilities 2
Direct lines
Contact
Share quantities, requirements, and timing.
Send requirementsCompany record
Profile information
- Founded
- 2018
- Website
- www.algotx.com
Source: company website
Start a conversation
Send your requirements
Quantities, certifications, delivery timing, and anything else needed to quote the work.